We think that Colgate-Palmolive stock (NYSE: CL) is currently a better pick over its industry peer – Kimberly-Clark stock (NYSE: KMB). CL stock trades at 3.5x trailing revenues, versus 2.1x for KMB.

Kimberly-Clark (KMB) came out with quarterly earnings of $1.50 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.51 per share a year ago. These figures are ...

Ergo, when we looked at the ROCE trends at Kimberly-Clark (NYSE:KMB), we liked what we saw. 0.31 = US$3.1b ÷ (US$17b - US$7.1b) (Based on the trailing twelve months to September 2024).

Greetings. Welcome to the Kimberly Clark 4Q 2024 earnings call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation ...

Greetings, welcome to the Kimberly-Clark 4Q 2024 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal ...

Concern that laws could be passed preventing firms from conducting business here Fine Gael MEP Regina Doherty. Photo: Collins Israel is likely to retaliate against exports to Ireland if the ...

© 2023 EDGAR®Online LLC, a subsidiary of OTC Markets Group. All rights reserved. EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...